- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Roche's discontinued Alzheimer's drug shows signs of preventing onset | ||
| Do | Pfizer sells 7.3% stake in Haleon for $3.3bn | ||
| Do | Oxford BioTherapeutics and Roche link on antibody cancer treatments | ||
| Do | Blood cancers dominate CAR-T pipeline | ||
| Mi | USPTO allows patents for Remedy's large hemispheric infarction drug | ||
| Mi | Sacklers to pay up to $7bn in Purdue Pharma's opioid settlement plan | ||
| Mi | Insight and insitro partner on AI model to seek ocular biomarkers | ||
| Mi | Arbor to advance gene editing treatments with $73.9m funding | ||
| 18.03. | Opko and Entera focus on oral care for obesity and metabolic disorders | ||
| 18.03. | Curevo procures $110m and former-GSK exec for shingles vaccine candidate | ||
| 18.03. | Health Canada approves Biogen's Skyclarys for Friedreich's ataxia | ||
| 18.03. | Big tech meets biotech: Recursion and the AI gold rush in pharma | ||
| 18.03. | AstraZeneca and Alteogen agree on ALT-B4 platform tech | ||
| 17.03. | Investigating key strategies for optimising clinical trial supply chains in 2025 | ||
| 17.03. | Incyte stock hit 11% despite paediatric dermatology trials hitting target | ||
| 17.03. | Latigo secures $150m for non-opioid pain treatment development | ||
| 17.03. | Clinical trial challenges in China: How a Sharp and ClinsChain pairing is breaking down barriers | ||
| 17.03. | Taiho outlays $1.14bn to acquire ADC specialist Araris | ||
| 17.03. | Azurity acquires Covis Pharma from existing investors | ||
| 17.03. | EC approves Bristol Myers Squibb's follicular lymphoma CAR T therapy | ||
| 14.03. | AstraZeneca director says AI must be a "thought partner" in drug discovery | ||
| 14.03. | Boehringer Ingelheim and Salipro enter drug discovery partnership | ||
| 14.03. | MeiraGTx and Hologen launch AI-backed gene therapy venture | ||
| 14.03. | EC approves Otsuka and Lundbeck's Rxulti for schizophrenia | ||
| 14.03. | Insilico raises $110m to develop drug pipeline and AI platform |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
